Abeceli tablet is an oral targeted CDK4/6 inhibitor, which can selectively inhibit cyclin-dependent kinase 4/6, restore cell cycle control and block tumor cell proliferation. It is generally suitable for breast cancer with hormone receptor positive and HER2 negative. However, some adverse reactions may occur, such as nausea, vomiting, stomachache, constipation, aphtha, loss of appetite, weight loss, alopecia, itching, rash, headache, taste change, dizziness and so on. After using Agbesi tablets, you must follow the doctor's advice when using Agbesi tablets, and don't take it yourself to avoid adverse reactions.
It should be noted that Agbesi tablets may cause harm to the fetus when used, so strict contraception is needed. Please tell your doctor if you are pregnant or planning to be pregnant. Moreover, a pregnancy test is needed before starting the treatment, and contraceptive measures should be taken during the treatment and at least 3 weeks after the last medication to prevent pregnancy.